Global Vitamin D Therapy Market to Reach $7.7 Billion by 2030

ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, May 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vitamin D Therapy Industry" - https://www.reportlinker.com/p06033260/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Vitamin D Therapy Market to Reach $7.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Vitamin D Therapy estimated at US$2.5 Billion in the year 2022, is projected to reach a revised size of US$7.7 Billion by 2030, growing at aCAGR of 15% over the period 2022-2030. Oral, one of the segments analyzed in the report, is projected to record 15.5% CAGR and reach US$5.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Parenteral segment is readjusted to a revised 14% CAGR for the next 8-year period.

The U.S. Market is Estimated at $734.1 Million, While China is Forecast to Grow at 14.3% CAGR

The Vitamin D Therapy market in the U.S. is estimated at US$734.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Select Competitors (Total 36 Featured)
- Abbott
- Alkem Laboratories Ltd.
- Cadila Healthcare Ltd.
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.


Read the full report: https://www.reportlinker.com/p06033260/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Vitamin D Therapy - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Vitamin D Therapy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 2: World Historic Review for Vitamin D Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for Vitamin D Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Osteoporosis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 5: World Historic Review for Osteoporosis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Osteoporosis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Rickets by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 8: World Historic Review for Rickets by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Rickets by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Muscle Weakness by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 11: World Historic Review for Muscle Weakness by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 12: World 16-Year Perspective for Muscle Weakness by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Autoimmune Disorders by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Autoimmune Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Autoimmune Disorders by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for Skin
Diseases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 17: World Historic Review for Skin Diseases by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Skin Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Prescription Drugs by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 20: World Historic Review for Prescription Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Prescription Drugs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for OTC
Drugs by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 23: World Historic Review for OTC Drugs by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 24: World 16-Year Perspective for OTC Drugs by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 25: World Vitamin D Therapy Market Analysis of Annual
Sales in US$ Million for Years 2014 through 2030

Table 26: World Recent Past, Current & Future Analysis for Oral
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 27: World Historic Review for Oral by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 28: World 16-Year Perspective for Oral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 29: World Recent Past, Current & Future Analysis for
Parenteral by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 30: World Historic Review for Parenteral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 31: World 16-Year Perspective for Parenteral by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 32: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 33: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 34: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 35: USA Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 36: USA Historic Review for Vitamin D Therapy by Route Of
Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 37: USA 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 38: USA Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 39: USA Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 40: USA 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 41: USA Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 42: USA Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 43: USA 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

CANADA
Table 44: Canada Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 45: Canada Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 46: Canada 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 47: Canada Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 48: Canada Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 49: Canada 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 50: Canada Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 51: Canada Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 52: Canada 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

JAPAN
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 53: Japan Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 54: Japan Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 55: Japan 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 56: Japan Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 57: Japan Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 58: Japan 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 59: Japan Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 60: Japan Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 61: Japan 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

CHINA
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 62: China Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 63: China Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 64: China 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 65: China Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 66: China Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 67: China 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 68: China Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 69: China Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 70: China 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

EUROPE
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 71: Europe Recent Past, Current & Future Analysis for
Vitamin D Therapy by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR

Table 72: Europe Historic Review for Vitamin D Therapy by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 73: Europe 16-Year Perspective for Vitamin D Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2014, 2023 & 2030

Table 74: Europe Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 76: Europe 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 77: Europe Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 78: Europe Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 79: Europe 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 80: Europe Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 81: Europe Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 82: Europe 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

FRANCE
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 83: France Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 84: France Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 85: France 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 86: France Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 87: France Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 88: France 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 89: France Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 90: France Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 91: France 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

GERMANY
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2023 (E)
Table 92: Germany Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 93: Germany Historic Review for Vitamin D Therapy by
Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 94: Germany 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 95: Germany Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 96: Germany Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 97: Germany 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 98: Germany Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 99: Germany Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 100: Germany 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

ITALY
Table 101: Italy Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 102: Italy Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 103: Italy 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 104: Italy Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 105: Italy Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 106: Italy 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 107: Italy Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 108: Italy Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 109: Italy 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

UNITED KINGDOM
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2023 (E)
Table 110: UK Recent Past, Current & Future Analysis for
Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 111: UK Historic Review for Vitamin D Therapy by Route Of
Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 112: UK 16-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2014, 2023 & 2030

Table 113: UK Recent Past, Current & Future Analysis for
Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 114: UK Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 115: UK 16-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 116: UK Recent Past, Current & Future Analysis for
Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 117: UK Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 118: UK 16-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 119: Rest of Europe Recent Past, Current & Future
Analysis for Vitamin D Therapy by Route Of Administration -
Oral and Parenteral - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 120: Rest of Europe Historic Review for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 121: Rest of Europe 16-Year Perspective for Vitamin D
Therapy by Route Of Administration - Percentage Breakdown of
Value Sales for Oral and Parenteral for the Years 2014, 2023 &
2030

Table 122: Rest of Europe Recent Past, Current & Future
Analysis for Vitamin D Therapy by Application - Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 123: Rest of Europe Historic Review for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 124: Rest of Europe 16-Year Perspective for Vitamin D
Therapy by Application - Percentage Breakdown of Value Sales
for Other Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2014, 2023 &
2030

Table 125: Rest of Europe Recent Past, Current & Future
Analysis for Vitamin D Therapy by Method - Prescription Drugs
and OTC Drugs - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 126: Rest of Europe Historic Review for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 127: Rest of Europe 16-Year Perspective for Vitamin D
Therapy by Method - Percentage Breakdown of Value Sales for
Prescription Drugs and OTC Drugs for the Years 2014, 2023 &
2030

ASIA-PACIFIC
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Asia-Pacific for 2023 (E)
Table 128: Asia-Pacific Recent Past, Current & Future Analysis
for Vitamin D Therapy by Route Of Administration - Oral and
Parenteral - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 129: Asia-Pacific Historic Review for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 130: Asia-Pacific 16-Year Perspective for Vitamin D
Therapy by Route Of Administration - Percentage Breakdown of
Value Sales for Oral and Parenteral for the Years 2014, 2023 &
2030

Table 131: Asia-Pacific Recent Past, Current & Future Analysis
for Vitamin D Therapy by Application - Other Applications,
Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders
and Skin Diseases - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 132: Asia-Pacific Historic Review for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033260/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001